Esperion Therapeutics (ESPR) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.21
-0.15
-0.08
-0.02

Details

Expected EPS
-0.078329
Actual EPS
-0.16
Surprise EPS
-0.08
Surprise Percent
-104.27%

Description

⁨Esperion Therapeutics⁩ (⁦ESPR⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts